Life Sciences Roundtable:
Critical Business Decisions During and After the COVID-19 Pandemic
Tuesday, April 28, 2020
Critical Business Decisions During and After the COVID-19 Pandemic
Tuesday, April 28, 2020
9:00 a.m. - 10:00 a.m. PT
11:00 a.m. - 12:00 p.m. CT
12:00 p.m. - 1:00 p.m. ET
11:00 a.m. - 12:00 p.m. CT
12:00 p.m. - 1:00 p.m. ET
Complimentary Webinar
Join us for a conversation with our panel of executives as they share how they have handled emerging issues during the COVID-19 pandemic, including:
- The impact of the healthcare crisis on their businesses
- Their experience with managing their workforce and “lessons learned”
- Experience with the CARES Act, including the Paycheck Protection Program loans
- Managing clients and engaging with consumers in the new business reality
- Innovations and opportunities amidst the crisis
- Their perspective on the future, post COVID
Panelists
- Williams Higgins, President, Ricola USA Inc.
- Vu Truong, Chief Executive Officer, Aridis Pharmaceuticals, Inc.
- Peter Webner, Chief Executive Officer, US, Zionexa
Moderated By
- Jeffrey Fessler, Partner, Sheppard Mullin
- Allison Fulton, Partner, Sheppard Mullin
*Webinar details will be sent upon registration*
Questions? Please contact Melissa Burgess via email.